InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.40
(
-1.01%
)
US TECH 100
17,116.00
(
-1.12%
)
Dow Jones
37,983.24
(
-1.05%
)
Brent Oil
86.03
(
-1.44%
)
Bitcoin
60,101.15
(
-5.85%
)
Post# of 17398
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Jesspro

Send PM Follow Ignore
Followers 41
Posts 6066
Boards Moderated 1
Alias Born 06/29/2011

Jesspro

Re: Lunacy_John Galt post# 4932

Friday, 07/21/2017 11:27:59 PM

Friday, July 21, 2017 11:27:59 PM

Post# of 17398
Today is cellcept, Next week or month, we'll hear back again about the long p3 trial or the other LN drugs currently in trial. Vid, myself and the rest of us have heard this time and time again in the other board.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AUPH News
More AUPH News
InvestorsHub NewsWire

FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM

Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!